Evolution of clinical and translational advances in the management of pediatric arteriovenous malformations.


Journal

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227

Informations de publication

Date de publication:
10 2023
Historique:
received: 23 06 2023
accepted: 09 07 2023
medline: 30 10 2023
pubmed: 18 7 2023
entrez: 18 7 2023
Statut: ppublish

Résumé

Arteriovenous malformations (AVMs) represent one of the most challenging diagnoses in pediatric neurosurgery. Until recently, the majority of AVMs was only identified after hemorrhage and primarily treated with surgery. However, recent advances in a wide range of fields-imaging, surgery, interventional radiology, radiation therapy, and molecular biology-have profoundly advanced the understanding and therapy of these complex lesions. Here we review the progress made in pediatric AVMs with a specific focus on innovations relevant to clinical care.

Identifiants

pubmed: 37462811
doi: 10.1007/s00381-023-06077-x
pii: 10.1007/s00381-023-06077-x
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2807-2818

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Luessenhop AJ, Spence WT (1960) Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation. J Am Med Assoc 172:1153–1155. (In eng). https://doi.org/10.1001/jama.1960.63020110001009
Gross BA, Scott RM, Smith ER (2014) Management of brain arteriovenous malformations. Lancet 383(9929):1635. https://doi.org/10.1016/S0140-6736(14)60785-6
doi: 10.1016/S0140-6736(14)60785-6 pubmed: 24814453
Lin N, Smith ER, Scott RM, Orbach DB (2015) Safety of neuroangiography and embolization in children: complication analysis of 697 consecutive procedures in 394 patients. J Neurosurg Pediatr 16(4):432–438. https://doi.org/10.3171/2015.2.PEDS14431
doi: 10.3171/2015.2.PEDS14431 pubmed: 26114994
Ravindra VM, Karsy M, Lanpher A et al (2019) A national analysis of 9655 pediatric cerebrovascular malformations: effect of hospital volume on outcomes. J Neurosurg Pediatr 1–10. https://doi.org/10.3171/2019.5.PEDS19155
Cassano R, Perri P, Esposito A et al (2023) Expanded polytetrafluoroethylene membranes for vascular stent coating: manufacturing, biomedical and surgical applications, innovations and case reports. Membranes (Basel) 13(2) (In eng). https://doi.org/10.3390/membranes13020240
Alexander MD, Cooke DL, Hallam DK, Kim H, Hetts SW, Ghodke BV (2016) Less can be more: targeted embolization of aneurysms associated with arteriovenous malformations unsuitable for surgical resection. Interv Neuroradiol 22(4):445–451. (In eng). https://doi.org/10.1177/1591019916641316
Flores BC, See AP, Weiner GM, Jankowitz BT, Ducruet AF, Albuquerque FC (2018) Use of the Apollo detachable-tip microcatheter for endovascular embolization of arteriovenous malformations and arteriovenous fistulas. J Neurosurg 130(3):963–971. (In eng). https://doi.org/10.3171/2017.9.Jns17397
Maimon S, Strauss I, Frolov V, Margalit N, Ram Z (2010) Brain arteriovenous malformation treatment using a combination of Onyx and a new detachable tip microcatheter, SONIC: short-term results. AJNR Am J Neuroradiol 31(5):947–954. (In eng). https://doi.org/10.3174/ajnr.A1959
Killer-Oberpfalzer M, Chapot R, Orion D, Barr JD, Cabiri O, Berenstein A (2022) Clinical experience with the Bendit steerable microcatheter: a new paradigm for endovascular treatment. J Neurointerv Surg (In eng). https://doi.org/10.1136/jnis-2022-019096
Vollherbst DF, Chapot R, Bendszus M, Möhlenbruch MA (2022) Glue, Onyx, Squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas. Clin Neuroradiol 32(1):25–38. (In eng). https://doi.org/10.1007/s00062-021-01066-6
Konya D, Yildirim O, Kurtkaya O et al (2005) Testing the angiogenic potential of cerebrovascular malformations by use of a rat cornea model: usefulness and novel assessment of changes over time. Neurosurgery 56(6):1339–1345; discussion 1345–1346. (In eng). https://doi.org/10.1227/01.neu.0000159886.08629.b7
Buell TJ, Ding D, Starke RM, Webster Crowley R, Liu KC (2014) Embolization-induced angiogenesis in cerebral arteriovenous malformations. J Clin Neurosci 21(11):1866–1871. (In eng). https://doi.org/10.1016/j.jocn.2014.04.010
Mamalui-Hunter M, Jiang T, Rich KM, Derdeyn CP, Drzymala RE (2011) Effect of liquid embolic agents on Gamma Knife surgery dosimetry for arteriovenous malformations. Clinical article. J Neurosurg 115(2):364–370. (In eng). https://doi.org/10.3171/2011.3.Jns10717
Halbach VV, Higashida RT, Yang P, Barnwell S, Wilson CB, Hieshima GB (1988) Preoperative balloon occlusion of arteriovenous malformations. Neurosurgery 22(2):301–308. (In eng). https://doi.org/10.1227/00006123-198802000-00004
Deveikis JP, Manz HJ, Luessenhop AJ et al (1994) A clinical and neuropathologic study of silk suture as an embolic agent for brain arteriovenous malformations. AJNR Am J Neuroradiol 15(2):263–271 (In eng)
pubmed: 8192071 pmcid: 8334617
Song JK, Eskridge JM, Chung EC et al (2000) Preoperative embolization of cerebral arteriovenous malformations with silk sutures: analysis and clinical correlation of complications revealed on computerized tomography scanning. J Neurosurg 92(6):955–960. https://doi.org/10.3171/jns.2000.92.6.0955 . (In eng)
doi: 10.3171/jns.2000.92.6.0955 pubmed: 10839255
Ding D, Sheehan JP, Starke RM et al (2015) Embolization of cerebral arteriovenous malformations with silk suture particles prior to stereotactic radiosurgery. J Clin Neurosci 22(10):1643–1649. https://doi.org/10.1016/j.jocn.2015.03.046 . (In eng)
doi: 10.1016/j.jocn.2015.03.046 pubmed: 26186966
Sorimachi T, Koike T, Takeuchi S et al (1999) Embolization of cerebral arteriovenous malformations achieved with polyvinyl alcohol particles: angiographic reappearance and complications. AJNR Am J Neuroradiol 20(7):1323–1328 (In eng)
pubmed: 10472993 pmcid: 7055976
Hamada JI, Kai Y, Mizuno T et al (2004) A nonadhesive liquid embolic agent of ethylene vinyl alcohol copolymer and ethanol mixture for cerebral arteriovenous malformations. Clinical experience. Interv Neuroradio 10 Suppl 1(Suppl 1):135–142. (In eng). https://doi.org/10.1177/15910199040100s123
U.S. Dept. of Health and Human Services PHS, Food and Drug Administration (1995) Target Therapeutics. Detachable Platinum Coil (Gugliemi Detachable Coil, GDC) 510(k) Premarket Notification. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K951256
Park KY, Kim JW, Kim BM et al (2019) Coil-protected technique for liquid embolization in neurovascular malformations. Korean J Radiol 20(8):1285–1292. (In eng). https://doi.org/10.3348/kjr.2019.0127
Gao X, Liang G, Li Z et al (2014) Transarterial coil-augmented Onyx embolization for brain arteriovenous malformation. Technique and experience in 22 consecutive patients. Interv Neuroradiol 20(1):83–90. (In eng). https://doi.org/10.15274/inr-2014-10012
Berenstein A, Fifi J (2018) Study of PHIL
Crowley RW, Ducruet AF, Kalani MY, Kim LJ, Albuquerque FC, McDougall CG (2015) Neurological morbidity and mortality associated with the endovascular treatment of cerebral arteriovenous malformations before and during the Onyx era. J Neurosurg 122(6):1492–1497. (In eng). https://doi.org/10.3171/2015.2.Jns131368
Behzadi F, Heiferman DM, Wozniak A et al (2022) Comparison of transarterial n-BCA and Onyx embolization of brain arteriovenous malformations: a single-center 18-year retrospective analysis. J Cerebrovasc Endovasc Neurosurg 24(2):144–153. (In eng). https://doi.org/10.7461/jcen.2022.E2021.12.003
Velat GJ, Reavey-Cantwell JF, Sistrom C et al (2008) Comparison of N-butyl cyanoacrylate and onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times. Neurosurgery 63(1 Suppl 1):ONS73–8; discussion ONS78–80. (In eng). https://doi.org/10.1227/01.neu.0000335015.83616.12
Lv X, Wu Z, Jiang C et al (2011) Complication risk of endovascular embolization for cerebral arteriovenous malformation. Eur J Radiol 80(3):776–779. (In eng). https://doi.org/10.1016/j.ejrad.2010.09.024
Yakes WF, Krauth L, Ecklund J et al (1997) Ethanol endovascular management of brain arteriovenous malformations: initial results. Neurosurgery 40(6):1145–1152; discussion 1152–1154. (In eng). https://doi.org/10.1097/00006123-199706000-00005
Settecase F, Hetts SW, Nicholson AD et al (2016) Superselective intra-arterial ethanol sclerotherapy of feeding artery and nidal aneurysms in ruptured cerebral arteriovenous malformations. AJNR Am J Neuroradiol 37(4):692–697. (In eng). https://doi.org/10.3174/ajnr.A4584
Yakes WF (2004) Endovascular management of high-flow arteriovenous malformations. Semin Intervent Radiol 21(1):49–58. (In eng). https://doi.org/10.1055/s-2004-831405
Berthelsen B, Löfgren J, Svendsen P (1990) Embolization of cerebral arteriovenous malformations with bucrylate. Experience in a first series of 29 patients. Acta Radiol 31(1):13–21. (In eng)
Brothers MF, Kaufmann JC, Fox AJ, Deveikis JP (1989) n-Butyl 2-cyanoacrylate–substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. AJNR Am J Neuroradiol 10(4):777–786 (In eng)
pubmed: 2505505 pmcid: 8332608
Fournier D, Terbrugge K, Rodesch G, Lasjaunias P (1990) Revascularization of brain arteriovenous malformations after embolization with bucrylate. Neuroradiology 32(6):497–501. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2287379
Debrun GM, Aletich V, Ausman JI, Charbel F, Dujovny M (1997) Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 40(1):112–120; discussion 120–121. (In eng)
U.S. Dept. of Health and Human Services PHS, Food and Drug Administration (2000) Medos International SARL. Trufill n-butyl Cyanoacrylate Liquid Embolic System 510(k) Premarket Notification. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p990040
Gounis MJ, Lieber BB, Wakhloo AK, Siekmann R, Hopkins LN (2002) Effect of glacial acetic acid and ethiodized oil concentration on embolization with N-butyl 2-cyanoacrylate: an in vivo investigation. AJNR Am J Neuroradiol 23(6):938–944 (In eng)
pubmed: 12063221 pmcid: 7976895
Moore C, Murphy K, Gailloud P (2006) Improved distal distribution of n-butyl cyanoacrylate glue by simultaneous injection of dextrose 5% through the guiding catheter: technical note. Neuroradiology 48(5):327–332. (In eng). https://doi.org/10.1007/s00234-006-0059-2
Taki W, Yonekawa Y, Iwata H, Uno A, Yamashita K, Amemiya H (1990) A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol 11(1):163–168 (In eng)
pubmed: 2105599 pmcid: 8332490
Katsaridis V, Papagiannaki C, Aimar E (2008) Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 50(7):589–597. (In eng). https://doi.org/10.1007/s00234-008-0382-x
Mounayer C, Hammami N, Piotin M et al (2007) Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28(3):518–523 (In eng)
pubmed: 17353327 pmcid: 7977844
U.S. Dept. of Health and Human Services PHS, Food and Drug Administration (2005) EV3 Neurovascular. Onyx Liquid Embolic System. 510(k) Premarket Notification. ( https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P030004 )
Loh Y, Duckwiler GR (2010) A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg 113(4):733–741. (In eng). https://doi.org/10.3171/2010.3.Jns09370
Siekmann R (2005) Basics and Principles in the Application of Onyx LD Liquid Embolic System in the Endovascular Treatment of Cerebral Arteriovenous Malformations. Interv Neuroradiol 11(Suppl 1):131–140. (In eng). https://doi.org/10.1177/15910199050110s117
Signorelli F, Gory B, Pelissou-Guyotat I et al (2014) Ruptured brain arteriovenous malformations associated with aneurysms: safety and efficacy of selective embolization in the acute phase of hemorrhage. Neuroradiology 56(9):763–769. (In eng). https://doi.org/10.1007/s00234-014-1395-2
van Rooij WJ, Jacobs S, Sluzewski M, van der Pol B, Beute GN, Sprengers ME (2012) Curative embolization of brain arteriovenous malformations with onyx: patient selection, embolization technique, and results. AJNR Am J Neuroradiol 33(7):1299–1304. (In eng). https://doi.org/10.3174/ajnr.A2947
De Leacy R, Ansari SA, Schirmer CM et al (2022) Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee. J Neurointerv Surg 14(11):1118–1124. (In eng). https://doi.org/10.1136/neurintsurg-2021-018632
Subat YW, Dasenbrock HH, Gross BA et al (2019) Periprocedural intracranial hemorrhage after embolization of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg 1–11. (In eng). https://doi.org/10.3171/2019.5.Jns183204
Paramasivam S, Niimi Y, Fifi J, Berenstein A (2013) Onyx embolization using dual-lumen balloon catheter: initial experience and technical note. J Neuroradiol 40(4):294–302. (In eng). https://doi.org/10.1016/j.neurad.2013.08.001
Iosif C, Almeida Filho JA, Gilbert CE et al (2022) Selective arterial temporary flow arrest with balloons during transvenous embolization for the treatment of brain arteriovenous malformations: a feasibility study with MRI-monitored adverse events. J Neurointerv Surg 14(12):1234–1238. (In eng). https://doi.org/10.1136/neurintsurg-2021-018097
Chapot R, Stracke P, Velasco A et al (2014) The pressure cooker technique for the treatment of brain AVMs. J Neuroradiol 41(1):87–91. (In eng). https://doi.org/10.1016/j.neurad.2013.10.001
De Sousa JMB, Iosif C, Sganzerla LZ et al (2020) Selection of patients for treatment of brain arteriovenous malformations by the transvenous approach: relationship with venous anatomy and risk of hemorrhagic complications. AJNR Am J Neuroradiol 41(12):2311–2316. (In eng). https://doi.org/10.3174/ajnr.A6810
Iosif C, Mendes GA, Saleme S et al (2015) Endovascular transvenous cure for ruptured brain arteriovenous malformations in complex cases with high Spetzler-Martin grades. J Neurosurg 122(5):1229–1238. (In eng). https://doi.org/10.3171/2014.9.Jns141714
Koyanagi M, Mosimann PJ, Nordmeyer H et al (2021) The transvenous retrograde pressure cooker technique for the curative embolization of high-grade brain arteriovenous malformations. J Neurointerv Surg 13(7):637–641. (In eng). https://doi.org/10.1136/neurintsurg-2020-016566
Groff MW, Adams DC, Kahn RA, Kumbar UM, Yang BY, Bederson JB (1999) Adenosine-induced transient asystole for management of a basilar artery aneurysm. Case report. J Neurosurg 91(4):687–690. (In eng). https://doi.org/10.3171/jns.1999.91.4.0687
Pile-Spellman J, Young WL, Joshi S et al (1999) Adenosine-induced cardiac pause for endovascular embolization of cerebral arteriovenous malformations: technical case report. Neurosurgery 44(4):881–886; discussion 886–887. (In eng). https://doi.org/10.1097/00006123-199904000-00117
Ghorbani M, Griessenauer CJ, Wipplinger C et al (2021) Adenosine-induced transient circulatory arrest in transvenous embolization of cerebral arteriovenous malformations. Neuroradiol J 34(5):509–516. (In eng). https://doi.org/10.1177/1971400921998972
Rangel-Castilla L, Shallwani H, Siddiqui AH (2019) Transvenous embolization of thalamic arteriovenous malformation under transient cardiac standstill. Neurosurg Focus 46(Suppl_1):V10. (In eng). https://doi.org/10.3171/2019.1.FocusVid.18416
Jagadeesan BD, Grande AW, Tummala RP (2018) Safety and feasibility of balloon-assisted embolization with Onyx of brain arteriovenous malformations revisited: personal experience with the scepter XC balloon microcatheter. Interv Neurol 7(6):439–444. (In eng). https://doi.org/10.1159/000490579
Manzoor MU, Almulhim IA, Alrashed AA, Althubait S, Alturki AY, Al-Qahtani SM (2023) Initial experience with Scepter Mini dual lumen balloon for embolization of cerebrovascular diseases. Journal of cerebrovascular and endovascular neurosurgery. https://doi.org/10.7461/jcen.2023.E2022.10.004
doi: 10.7461/jcen.2023.E2022.10.004 pubmed: 36800673 pmcid: 10318239
Weinstock P, Prabhu SP, Flynn K, Orbach DB, Smith E (2015) Optimizing cerebrovascular surgical and endovascular procedures in children via personalized 3D printing. J Neurosurg Pediatr 1–6. https://doi.org/10.3171/2015.3.PEDS14677
Gross BA, Storey A, Orbach DB, Scott RM, Smith ER (2015) Microsurgical treatment of arteriovenous malformations in pediatric patients: the Boston Children’s Hospital experience. J Neurosurg Pediatr 15(1):71–77. https://doi.org/10.3171/2014.9.PEDS146
doi: 10.3171/2014.9.PEDS146 pubmed: 25360855
Lin N, Smith ER, Scott RM, Orbach DB (2015) Safety of neuroangiography and embolization in children: complication analysis of 697 consecutive procedures in 394 patients. J Neurosurg Pediatr 1–7. https://doi.org/10.3171/2015.2.PEDS14431
Pertuiset B, Ancri D, Kinuta Y et al (1991) Classification of supratentorial arteriovenous malformations. A score system for evaluation of operability and surgical strategy based on an analysis of 66 cases. Acta Neurochir (Wien) 110(1–2):6–16. https://doi.org/10.1007/BF01402041
Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65(4):476–483. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3760956
Hamilton MG, Spetzler RF (1994) The prospective application of a grading system for arteriovenous malformations. Neurosurgery 34(1):2–6; discussion 6–7. ( http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8121564 )
Spetzler RF, Ponce FA (2011) A 3-tier classification of cerebral arteriovenous malformations. Clinical article J Neurosurg 114(3):842–849. https://doi.org/10.3171/2010.8.JNS10663
doi: 10.3171/2010.8.JNS10663 pubmed: 20932095
Lawton MT (2003) Spetzler-Martin Grade III arteriovenous malformations: surgical results and a modification of the grading scale. Neurosurgery 52(4):740–748; discussion 748–749. (In eng). https://doi.org/10.1227/01.neu.0000053220.02268.9c
Lawton MT, Kim H, McCulloch CE, Mikhak B, Young WL (2010) A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery 66(4):702–713; discussion 713. (In eng). https://doi.org/10.1227/01.Neu.0000367555.16733.E1
Andrade-Souza YM, Zadeh G, Ramani M, Scora D, Tsao MN, Schwartz ML (2005) Testing the radiosurgery-based arteriovenous malformation score and the modified Spetzler-Martin grading system to predict radiosurgical outcome. J Neurosurg 103(4):642–648. (In eng). https://doi.org/10.3171/jns.2005.103.4.0642
Pollock BE (2013) Development and testing of a radiosurgery-based arteriovenous malformation grading system. Prog Neurol Surg 27:58–66. https://doi.org/10.1159/000341620
doi: 10.1159/000341620 pubmed: 23258509
Pollock BE, Flickinger JC (2008) Modification of the radiosurgery-based arteriovenous malformation grading system. Neurosurgery 63(2):239–243; discussion 243. https://doi.org/10.1227/01.NEU.0000315861.24920.92
Wegner RE, Oysul K, Pollock BE et al (2011) A modified radiosurgery-based arteriovenous malformation grading scale and its correlation with outcomes. Int J Radiat Oncol Biol Phys 79(4):1147–1150. (In eng). https://doi.org/10.1016/j.ijrobp.2009.12.056
Starke RM, Yen CP, Ding D, Sheehan JP (2013) A practical grading scale for predicting outcome after radiosurgery for arteriovenous malformations: analysis of 1012 treated patients. J Neurosurg 119(4):981–987. https://doi.org/10.3171/2013.5.JNS1311
doi: 10.3171/2013.5.JNS1311 pubmed: 23829820
Gupta R, Adeeb N, Moore JM et al (2016) Validity assessment of grading scales predicting complications from embolization of cerebral arteriovenous malformations. Clin Neurol Neurosurg 151:102–107. (In eng). https://doi.org/10.1016/j.clineuro.2016.10.019
Jin H, Jiang Y, Ge H et al (2017) Comparison of grading scales regarding perioperative complications and clinical outcomes of brain arteriovenous malformations after endovascular therapy-multicenter study. World neurosurgery 106:394–401. (In eng). https://doi.org/10.1016/j.wneu.2017.07.020
Pulli B, Stapleton CJ, Walcott BP et al (2019) Comparison of predictive grading systems for procedural risk in endovascular treatment of brain arteriovenous malformations: analysis of 104 consecutive patients. J Neurosurg 1–9. (In eng). https://doi.org/10.3171/2019.4.Jns19266
Feliciano CE, de León-Berra R, Hernández-Gaitán MS, Rodríguez-Mercado R (2010) A proposal for a new arteriovenous malformation grading scale for neuroendovascular procedures and literature review. P R Health Sci J 29(2):117–120 (In eng)
pubmed: 20496526 pmcid: 3101505
Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui AH, Levy EI (2015) A proposed grading system for endovascular treatment of cerebral arteriovenous malformations: Buffalo score. Surg Neurol Int 6:3. (In eng). https://doi.org/10.4103/2152-7806.148847
Lopes DK, Moftakhar R, Straus D, Munich SA, Chaus F, Kaszuba MC (2016) Arteriovenous malformation embocure score: AVMES. J Neurointerv Surg 8(7):685–691. (In eng). https://doi.org/10.1136/neurintsurg-2015-011779
Feghali J, Yang W, Xu R et al (2019) R(2)eD AVM Score. Stroke J Cereb Circ 50(7):1703–1710. (In eng). https://doi.org/10.1161/strokeaha.119.025054
Rangwala SD, Albanese JS, Slingerland AL et al (2023) External validation of the R2eD AVM scoring system to assess rupture risk in pediatric AVM patients. J Neurosurg Pediatr 31(5):469–475. https://doi.org/10.3171/2023.1.PEDS22310
doi: 10.3171/2023.1.PEDS22310 pubmed: 36840738
Chen Y, Han H, Meng X et al (2023) Development and validation of a scoring system for hemorrhage risk in brain arteriovenous malformations. JAMA Netw Open 6(3):e231070. (In eng). https://doi.org/10.1001/jamanetworkopen.2023.1070
Stapf C, Mast H, Sciacca RR et al (2006) Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 66(9):1350–1355. (In eng). https://doi.org/10.1212/01.wnl.0000210524.68507.87
Ter Brugge K, Lasjaunias P, Chiu M, Flodmark O, Chuang S, Burrows P (1986) Pediatric surgical neuroangiography. A multicentre approach. Acta Radiol Suppl 369:692–693. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2980598
Humphreys RP, Hoffman HJ, Drake JM, Rutka JT (1996) Choices in the 1990s for the management of pediatric cerebral arteriovenous malformations. Pediatr Neurosurg 25(6):277–285. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9348147
Hoh BL, Chapman PH, Loeffler JS, Carter BS, Ogilvy CS (2002) Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery 51(2):303–309; discussion 309–311. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12182768
Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS (2004) Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 39(3):590–600. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14981454
Raygor K PR, Rutledge C et al (2022) Socioeconomic factors associated with pediatric moyamoya disease hospitalizations: a nationwide cross-sectional study. J Neurosurg Pediatr. In press
Vinchon M, Toubol A, Karnoub MA, Aboukais R, Leclerc X, Reyns N (2023) Unruptured cerebral arteriovenous malformation in children: outcome in treated and untreated patients. Neurochirurgie 69(3):101440. https://doi.org/10.1016/j.neuchi.2023.101440
Montaser A, Smith ER (2021) Intracranial vascular abnormalities in children. Pediatr Clin North Am 68(4):825–843. https://doi.org/10.1016/j.pcl.2021.04.010
doi: 10.1016/j.pcl.2021.04.010 pubmed: 34247712
Fullerton HJ, Achrol AS, Johnston SC et al (2005) Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke; a journal of cerebral circulation 36(10):2099–2104. https://doi.org/10.1161/01.STR.0000181746.77149.2b
doi: 10.1161/01.STR.0000181746.77149.2b
Chowdhury SS, See AP, Eriksson LP et al (2022) Closing the gap in pediatric hemorrhagic stroke: a systematic review. Semin Pediatr Neurol 43:101001. https://doi.org/10.1016/j.spen.2022.101001
Ciochon UM, Bindslev JBB, Hoei-Hansen CE et al (2022) Causes and risk factors of pediatric spontaneous intracranial hemorrhage-a systematic review. Diagnostics (Basel) 12(6). https://doi.org/10.3390/diagnostics12061459
Ferriero DM, Fullerton HJ, Bernard TJ et al (2019) Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation 50(3):e51–e96. https://doi.org/10.1161/STR.0000000000000183
doi: 10.1161/STR.0000000000000183
Sanchez-Mejia RO, Chennupati SK, Gupta N, Fullerton H, Young WL, Lawton MT (2006) Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg 105(2 Suppl):82–87. https://doi.org/10.3171/ped.2006.105.2.82
doi: 10.3171/ped.2006.105.2.82 pubmed: 16922067
Mohr JP, Parides MK, Stapf C et al (2014) Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 383(9917):614–621. https://doi.org/10.1016/S0140-6736(13)62302-8
doi: 10.1016/S0140-6736(13)62302-8 pubmed: 24268105
Pinkiewicz M, Pinkiewicz M, Walecki J, Zawadzki M (2022) State of the art in the role of endovascular embolization in the management of brain arteriovenous malformations-a systematic review. J Clin Med 11(23). https://doi.org/10.3390/jcm11237208
Ravindra VM, Bollo RJ, Eli IM et al (2019) A study of pediatric cerebral arteriovenous malformations: clinical presentation, radiological features, and long-term functional and educational outcomes with predictors of sustained neurological deficits. J Neurosurg Pediatr 24(1):1–8. https://doi.org/10.3171/2019.2.PEDS18731
doi: 10.3171/2019.2.PEDS18731 pubmed: 30952115
Burke RM, Chen CJ, Ding D et al (2021) Effect of prior embolization on outcomes after stereotactic radiosurgery for pediatric brain arteriovenous malformations: an international multicenter study. Neurosurgery 89(4):672–679. https://doi.org/10.1093/neuros/nyab245
doi: 10.1093/neuros/nyab245 pubmed: 34333653
De Leacy R, Ansari SA, Schirmer CM et al (2022) Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee. J Neurointerv Surg 14(11):1118–1124. https://doi.org/10.1136/neurintsurg-2021-018632
doi: 10.1136/neurintsurg-2021-018632 pubmed: 35414599
Rodriguez-Calienes A, Vivanco-Suarez J, Borjas-Calderon NF et al (2023) Curative embolization of ruptured pediatric cerebral arteriovenous malformations. Clin Neurol Neurosurg 227:107663. https://doi.org/10.1016/j.clineuro.2023.107663
Razavi SAS, Mirbolouk MH, Gorji R et al (2022) Endovascular treatment as the first-line approach for cure of low-grade brain arteriovenous malformation. Neurosurg Focus 53(1):E8. https://doi.org/10.3171/2022.4.FOCUS22122
doi: 10.3171/2022.4.FOCUS22122 pubmed: 35901720
Hak JF, Boulouis G, Kerleroux B et al (2022) Pediatric brain arteriovenous malformation recurrence: a cohort study, systematic review and meta-analysis. J Neurointerv Surg 14(6):611–617. https://doi.org/10.1136/neurintsurg-2021-017777
doi: 10.1136/neurintsurg-2021-017777 pubmed: 34583986
Lindqvist M, Karlsson B, Guo WY, Kihlstrom L, Lippitz B, Yamamoto M (2000) Angiographic long-term follow-up data for arteriovenous malformations previously proven to be obliterated after gamma knife radiosurgery. Neurosurgery 46(4):803–808; discussion 809–810. http://www.ncbi.nlm.nih.gov/pubmed/10764252
Winkler EA, Lu A, Morshed RA et al (2020) Bringing high-grade arteriovenous malformations under control: clinical outcomes following multimodality treatment in children. J Neurosurg Pediatr 26(1):82–91. https://doi.org/10.3171/2020.1.PEDS19487
doi: 10.3171/2020.1.PEDS19487 pubmed: 32276243
Yamamoto M, Akabane A, Matsumaru Y, Higuchi Y, Kasuya H, Urakawa Y (2012) Long-term follow-up results of intentional 2-stage Gamma Knife surgery with an interval of at least 3 years for arteriovenous malformations larger than 10 cm(3). J Neurosurg 117(Suppl):126–134. https://doi.org/10.3171/2012.6.GKS12757
doi: 10.3171/2012.6.GKS12757 pubmed: 23205800
Seymour ZA, Sneed PK, Gupta N et al (2016) Volume-staged radiosurgery for large arteriovenous malformations: an evolving paradigm. J Neurosurg 124(1):163–174. https://doi.org/10.3171/2014.12.JNS141308
doi: 10.3171/2014.12.JNS141308 pubmed: 26140495
Nicolato A, Longhi M, Tommasi N et al (2015) Leksell Gamma Knife for pediatric and adolescent cerebral arteriovenous malformations: results of 100 cases followed up for at least 36 months. J Neurosurg Pediatr 16(6):736–747. https://doi.org/10.3171/2015.4.PEDS158
doi: 10.3171/2015.4.PEDS158 pubmed: 26339954
Thiex R, Mulliken JB, Revencu N et al (2010) A novel association between RASA1 mutations and spinal arteriovenous anomalies. AJNR Am J Neuroradiol 31(4):775–779. (In eng). https://doi.org/10.3174/ajnr.A1907
Lasjaunias P (1997) Vascular Diseases in Neonates. Springer Verlag, Infants and Children
doi: 10.1007/978-3-662-10740-9
Faughnan ME, Palda VA, Garcia-Tsao G et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48(2):73–87. https://doi.org/10.1136/jmg.2009.069013
doi: 10.1136/jmg.2009.069013 pubmed: 19553198
Latino GA, Al-Saleh S, Carpenter S, Ratjen F (2014) The diagnostic yield of rescreening for arteriovenous malformations in children with hereditary hemorrhagic telangiectasia. J Pediatr 165(1):197–199. https://doi.org/10.1016/j.jpeds.2014.03.040
doi: 10.1016/j.jpeds.2014.03.040 pubmed: 24797954
Shovlin CL, Guttmacher AE, Buscarini E et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91(1):66–67. https://www.ncbi.nlm.nih.gov/pubmed/10751092
Starke RM, Ding D, Kano H et al (2017) International multicenter cohort study of pediatric brain arteriovenous malformations. Part 2: Outcomes after stereotactic radiosurgery. J Neurosurg Pediatr 19(2):136–148. https://doi.org/10.3171/2016.9.PEDS16284
Borcek AO, Emmez H, Akkan KM et al (2014) Gamma Knife radiosurgery for arteriovenous malformations in pediatric patients. Childs Nerv Syst 30(9):1485–1492. https://doi.org/10.1007/s00381-014-2469-5
doi: 10.1007/s00381-014-2469-5 pubmed: 24972531
Potts MB, Jahangiri A, Jen M et al (2014) Deep arteriovenous malformations in the basal ganglia, thalamus, and insula: multimodality management, patient selection, and results. World neurosurgery 82(3–4):386–394. https://doi.org/10.1016/j.wneu.2014.03.033
doi: 10.1016/j.wneu.2014.03.033 pubmed: 24657255 pmcid: 4169357
Blauwblomme T, Bourgeois M, Meyer P et al (2014) Long-term outcome of 106 consecutive pediatric ruptured brain arteriovenous malformations after combined treatment. Stroke; a journal of cerebral circulation 45(6):1664–1671. https://doi.org/10.1161/STROKEAHA.113.004292
doi: 10.1161/STROKEAHA.113.004292
Reitz M, von Spreckelsen N, Vettorazzi E et al (2016) Angioarchitectural risk factors for hemorrhage and clinical long-term outcome in pediatric patients with cerebral arteriovenous malformations. World neurosurgery 89:540–551. https://doi.org/10.1016/j.wneu.2016.02.050
doi: 10.1016/j.wneu.2016.02.050 pubmed: 26898497
Patibandla MR, Ding D, Xu Z, Sheehan JP (2017) Stereotactic radiosurgery for pediatric high-grade brain arteriovenous malformations: our experience and review of literature. World neurosurgery 102:613–622. https://doi.org/10.1016/j.wneu.2017.03.064
doi: 10.1016/j.wneu.2017.03.064 pubmed: 28344181
Aboukais R, Vinchon M, Quidet M, Bourgeois P, Leclerc X, Lejeune JP (2017) Reappearance of arteriovenous malformations after complete resection of ruptured arteriovenous malformations: true recurrence or false-negative early postoperative imaging result? J Neurosurg 126(4):1088–1093. https://doi.org/10.3171/2016.3.JNS152846
doi: 10.3171/2016.3.JNS152846 pubmed: 27231973
Morgenstern PF, Hoffman CE, Kocharian G, Singh R, Stieg PE, Souweidane MM (2015) Postoperative imaging for detection of recurrent arteriovenous malformations in children. J Neurosurg Pediatr 1–7. https://doi.org/10.3171/2015.6.PEDS14708
Lang SS, Beslow LA, Bailey RL et al (2012) Follow-up imaging to detect recurrence of surgically treated pediatric arteriovenous malformations. J Neurosurg Pediatr 9(5):497–504. https://doi.org/10.3171/2012.1.PEDS11453
doi: 10.3171/2012.1.PEDS11453 pubmed: 22546027 pmcid: 3484378
Graffeo CS, Bhandarkar AR, Carlstrom LP et al (2023) That which is unseen: 3D printing for pediatric cerebrovascular education. Childs Nerv Syst. https://doi.org/10.1007/s00381-023-05987-0
doi: 10.1007/s00381-023-05987-0 pubmed: 37272936
Fehnel KP, Penn DL, Duggins-Warf M et al (2020) Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients. Exp Mol Med 52(4):658–671. https://doi.org/10.1038/s12276-020-0414-0
doi: 10.1038/s12276-020-0414-0 pubmed: 32286515 pmcid: 7210966
Goss JA, Huang AY, Smith E et al (2019) Somatic mutations in intracranial arteriovenous malformations. PLoS One 14(12):e0226852. https://doi.org/10.1371/journal.pone.0226852
Fish JE, Flores-Suarez CP, Boudreau E et al (2020) Somatic gain of KRAS function in the endothelium is sufficient to cause vascular malformations that Require MEK but not PI3K Signaling. Circ Res. https://doi.org/10.1161/CIRCRESAHA.119.316500
doi: 10.1161/CIRCRESAHA.119.316500 pubmed: 32552404 pmcid: 7447191
Kahle KT, Duran D, Smith ER (2023) Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics. J Neurosurg Pediatr 31(3):228–237. https://doi.org/10.3171/2022.12.PEDS22332
doi: 10.3171/2022.12.PEDS22332 pubmed: 36609371
Zeng X, Hunt A, Jin SC, Duran D, Gaillard J, Kahle KT (2019) EphrinB2-EphB4-RASA1 signaling in human cerebrovascular development and disease. Trends Mol Med 25(4):265–286. https://doi.org/10.1016/j.molmed.2019.01.009
doi: 10.1016/j.molmed.2019.01.009 pubmed: 30819650 pmcid: 6456402
Copelan A, Drocton G, Caton MT et al (2020) Brain arteriovenous malformation recurrence after apparent microsurgical cure: increased risk in children who present with arteriovenous malformation rupture. Stroke; a journal of cerebral circulation 51(10):2990–2996. https://doi.org/10.1161/STROKEAHA.120.030135
doi: 10.1161/STROKEAHA.120.030135
Sesen J, Driscoll J, Moses-Gardner A, Orbach DB, Zurakowski D, Smith ER (2021) Non-invasive urinary biomarkers in moyamoya disease. Front Neurol 12:661952. https://doi.org/10.3389/fneur.2021.661952
Baxter PA, Su JM, Onar-Thomas A et al (2020) A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro Oncol 22(6):875–885. https://doi.org/10.1093/neuonc/noaa016
doi: 10.1093/neuonc/noaa016 pubmed: 32009149 pmcid: 7283021
Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA (2008) Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res 14(8):2378–2386. (In eng). https://doi.org/10.1158/1078-0432.Ccr-07-1253
Smith ER, Manfredi M, Scott RM, Black PM, Moses MA (2007) A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery 60(6):E1148–9; discussion E1149. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17538362

Auteurs

Alfred P See (AP)

Department of Neurosurgery, Boston Children's Hospital and Harvard Medical School, 300 Longwood Avenue, 02115, Boston, MA, USA.

Edward R Smith (ER)

Department of Neurosurgery, Boston Children's Hospital and Harvard Medical School, 300 Longwood Avenue, 02115, Boston, MA, USA. edward.smith@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH